ArticleBMC gastroenterology2025

Efficacy and safety of vedolizumab in elderly and younger patients with moderate-to-severe ulcerative colitis: a retrospective real-world study in China.

Hao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.